| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/04/1994 | WO1994016726A1 Carcinoma associated antigen (ng1) monoclonal antibodies against ng1, methods of producing these antibodies and use therefor |
| 08/04/1994 | WO1994016724A1 Prevention and treatment of cytomegalovirus using aminopeptidase |
| 08/04/1994 | WO1994016723A2 Wound healing composition |
| 08/04/1994 | WO1994016722A1 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties |
| 08/04/1994 | WO1994016721A1 Methods of treatment using ciliary neurotrophic factor |
| 08/04/1994 | WO1994016720A1 COMPOSITIONS CONTAINING TRANSFORMING GROWTH FACTOR β STABILIZED BY GLYCOSAMINOGLYCANS |
| 08/04/1994 | WO1994016719A1 Combination of a soluble complement receptor -1(scr1) and an amidinophenyl or amidino naphthyl-ester for treating inflammation |
| 08/04/1994 | WO1994016718A1 Genetic modification of neural stem cells |
| 08/04/1994 | WO1994016717A1 Method of treating diabetes mellitus |
| 08/04/1994 | WO1994016716A1 Recombinant virus immunotherapy |
| 08/04/1994 | WO1994016715A1 Selective cell proliferation |
| 08/04/1994 | WO1994016713A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
| 08/04/1994 | WO1994016688A1 Nutritive composition |
| 08/04/1994 | WO1994016681A1 Recombinant living subunit vaccine composition and process for its preparation |
| 08/04/1994 | WO1994016557A1 Transgenic animal model system for human cutaneous melanoma |
| 08/04/1994 | WO1994013808A3 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 08/04/1994 | WO1994013789A3 Oligonucleotides with rna cleavage activity |
| 08/04/1994 | WO1994012650A3 Activating expression of an amplifying endogenous gene by homologous recombination |
| 08/04/1994 | WO1994012637A3 Novel human amyloid protein precursor homologue and kunitz-type inhibitors |
| 08/04/1994 | WO1993025583A3 Proteinoid carriers and methods for preparation and use thereof |
| 08/04/1994 | CA2154902A1 Recombinant living subunit vaccine composition and process for its preparation |
| 08/04/1994 | CA2154896A1 Immunoreactive reagents employing heterodimers |
| 08/04/1994 | CA2154882A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
| 08/04/1994 | CA2154787A1 Selective cell proliferation |
| 08/04/1994 | CA2154487A1 Vaccines and methods for preventing and treating fescue toxicosis in herbivores |
| 08/04/1994 | CA2154468A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
| 08/04/1994 | CA2154346A1 Prevention and treatment of cytomegalovirus using aminopeptidase |
| 08/04/1994 | CA2154278A1 Anti-lfa-1 monoclonal antibodies used for the preparation of a medecine prenventing the rejection of grafted organs |
| 08/04/1994 | CA2154171A1 Max-interacting proteins and related molecules and methods |
| 08/04/1994 | CA2154078A1 Wound healing composition |
| 08/04/1994 | CA2153802A1 Chimeric selectins as simultaneous blocking agents for component selectin function |
| 08/04/1994 | CA2153797A1 Combination of a soluble complement receptor-1(scri) and an amidinophenyl or amidinonaphthyl-ester for treating inflammation |
| 08/04/1994 | CA2153790A1 Human monoclonal antibodies to cytomegalovirus |
| 08/04/1994 | CA2153582A1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 08/04/1994 | CA2132871A1 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties |
| 08/04/1994 | CA2132637A1 Icam-related protein |
| 08/03/1994 | EP0609078A1 Formulations containing unsaturated fatty acids |
| 08/03/1994 | EP0608759A2 Piperazinderivatives |
| 08/03/1994 | EP0608546A2 Glia activating factor (GAF), antibodies against it and their uses |
| 08/03/1994 | EP0608341A1 Enzyme-orthokeratology |
| 08/03/1994 | EP0608334A1 Sperm surface protein |
| 08/03/1994 | EP0608313A1 Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
| 08/03/1994 | EP0608261A1 Immunoreactive hepatitis c virus polypeptide compositions |
| 08/03/1994 | EP0608260A1 Peptide inhibitors of inflammation mediated by selectins |
| 08/03/1994 | EP0608217A1 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition |
| 08/03/1994 | EP0608212A1 Method of treating viral infection |
| 08/03/1994 | EP0419534B1 Wound healing |
| 08/03/1994 | CN1090326A Mammalian receptors for interleukin-10 (IL-10) |
| 08/03/1994 | CN1090289A Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 08/03/1994 | CN1090201A Angiotensin converting enzyme inhibitor and method for preparing same |
| 08/03/1994 | CN1090175A Fortifier which promotes growth of erythrocytes and prevents from anemia |
| 08/03/1994 | CA2114611A1 Method of reversing immunosuppression in vaccines |
| 08/02/1994 | US5334708 Method for radiolabeling monovalent antibody fragments |
| 08/02/1994 | US5334706 Administration of low dose hemoglobin to increase perfusion |
| 08/02/1994 | US5334705 Blood substitutes |
| 08/02/1994 | US5334704 Glycoprotein isolated from ganoderma having immunosuppressive activity |
| 08/02/1994 | US5334702 Compositions which are immunologically crossreactive with antibodies and preparative methods therefor |
| 08/02/1994 | US5334617 Preventing food spoilage and animal protein aging |
| 08/02/1994 | US5334612 Solid, semisolid, solution, suspension or emulsion dosage unit |
| 08/02/1994 | US5334584 Recombinant, non-glycosylated bpi protein and uses thereof |
| 08/02/1994 | US5334582 Preventing or treating bacterial infections in acidic environment by contacting bacteria with lanthionine-containing bacteriocin and chelating agent in carrier |
| 08/02/1994 | US5334531 Plasmid vector for expression in bacillus and used for cloning the structural gene which codes for the human growth hormone and a method of producing the hormone |
| 08/02/1994 | US5334511 Microorganism escherichia contains recombiant DNA, culturing |
| 08/02/1994 | US5334395 Method of treating an epstein-barr viral infection |
| 08/02/1994 | US5334394 A core particle with a surface coatings consisting of maltose, cellobiose, trehalose, isomaltose, nystose, maltotriose and nitrocellulose, bonding with immobilized virus cells; aids vaccines |
| 08/02/1994 | US5334391 Intracellularly cleavable compounds |
| 08/02/1994 | US5334383 Concurrent with colchicine |
| 08/02/1994 | US5334380 Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension |
| 08/02/1994 | CA1331157C Method for producing factor viii:c-type proteins |
| 08/02/1994 | CA1331134C Purification of pertussis toxins |
| 08/02/1994 | CA1331133C Pharmaceutical growth hormone formulations |
| 08/02/1994 | CA1331132C Method of treatment for non-specific inflammation |
| 08/02/1994 | CA1331131C Cyclic peptides as promoters of absorption on administration onto the mucosa |
| 07/30/1994 | CA2114361A1 Piperazine derivatives |
| 07/28/1994 | DE4302060A1 Use of bromelain as CD44 surface molecule modifier |
| 07/28/1994 | CA2114349A1 Formulations containing unsaturated fatty acids |
| 07/27/1994 | EP0608207A1 Nanocapsule containing pharmaceutical compositions |
| 07/27/1994 | EP0608121A1 Fibrinogen processing apparatus, method and container |
| 07/27/1994 | EP0608004A2 Human DNA in the diagnosis of retinoblastoma |
| 07/27/1994 | EP0607593A2 Process for obtaining cell cultures with a higher content of autologous cytonines |
| 07/27/1994 | EP0607408A1 Transvascular and intracellular delivery of lipidized proteins |
| 07/27/1994 | EP0607392A1 Plasma fraction purification |
| 07/27/1994 | EP0607353A1 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 07/27/1994 | EP0607346A1 Collagen constructs |
| 07/27/1994 | EP0607332A1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 07/27/1994 | EP0607325A1 PARATHYROID HORMONE ANALOGUES SUBSTITUTED AT aa?25,26,27 AND USE IN OSTEOPOROSIS TREATMENT |
| 07/27/1994 | EP0607309A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 07/27/1994 | EP0607297A1 Hormone analogs with multiple ctp extensions |
| 07/27/1994 | EP0607278A1 Method for enhancing gut absorption |
| 07/27/1994 | EP0607275A1 Treating ophthalmic fibrosis using interferon-alpha |
| 07/27/1994 | EP0607247A1 Production of gpa neurotrophic factor |
| 07/27/1994 | EP0607229A1 Pharmaceutical compositions comprising a calcitonin, a glycyrrhizinate as absorption enhancer and benzyl |
| 07/27/1994 | EP0607206A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 07/27/1994 | EP0607156A1 Process for producing preserved medicaments containing human proteins for the purposes of infusion or injection. |
| 07/27/1994 | EP0580790A4 Method for potentiating primary drugs in treating multidrug resistant cells |
| 07/27/1994 | EP0576589A4 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 07/27/1994 | EP0506769B1 Pharmaceutical composition for treating or preventing retroviral infections |
| 07/27/1994 | EP0491713B1 Rubella e1 and c peptides |
| 07/27/1994 | EP0478792B1 High-protein high-viscosity alimentary food composition |
| 07/27/1994 | EP0414816B1 Induction of tolerance to a foreign antigen |